Welcome to the Precision BioSciences Patient Community News page. Here, you can find and download our latest newsletters created for the Duchenne muscular dystrophy (DMD) community, with updates on our research, progress, and commitment to patients and families.
Dear Duchenne Community Newsletter:
First patient has been dosed in the FUNCTION-DMD clinical trial, a major step forward for our DMD gene editing program.
August 24, 2026
Dear Duchenne Community Newsletter:
First clinical trial site is now open at Arkansas Children's Hospital (Little Rock, AR) with Dr. Aravindhan Veerapandiyan as the study’s principal investigator.
April 28, 2026